Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

229 studies match

clinicaltrialsPublishedShowing 51–100 of 229 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05325866	A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression(FORTITUDE-301)	terminated	Phase 1 / Phase 2	260	AmgenINDUSTRY	26	Jun 22, 2026	clinicaltrials
NCT03441113	Extended Access of Momelotinib in Adults With Myelofibrosis	active not recruiting	Phase 2	237	GlaxoSmithKlineINDUSTRY	20	Jun 18, 2026	clinicaltrials